Pediatric Nephrology

, Volume 32, Issue 6, pp 1029–1033 | Cite as

Marked increase in urinary excretion of apolipoproteins in children with nephrolithiasis associated with hypercalciuria

  • Larisa Kovacevic
  • Hong Lu
  • Joseph A. Caruso
  • Tuhina Govil-Dalela
  • Ronald Thomas
  • Yegappan Lakshmanan
Original Article



Using a proteomic approach, we aimed to identify and compare the urinary excretion of proteins involved in lipid transport and metabolism in children with kidney stones and hypercalciuria (CAL), hypocitraturia (CIT), and normal metabolic work-up (NM), and in healthy controls (HCs). Additionally, we aimed to confirm these results using ELISA, and to examine the relationship between the urinary excretion of selected proteins with demographic, dietary, blood, and urinary parameters.


Prospective, controlled, pilot study of pooled urine from CAL, CIT, and NM versus age- and gender-matched HCs, using liquid chromatography-mass spectrometry. Relative protein abundance was estimated using spectral counting. Results were confirmed by ELISA performed on individual samples.


Of the 1,813 proteins identified, 230 met the above criteria. Of those, 5 proteins (apolipoprotein A-II [APOA2]; apolipoprotein A-IV [APOA4]; apolipoprotein C-III [APOA3]; fatty acid-binding protein, liver [FABPL]; fatty acid-binding protein, adipocyte [FABP4]) involved in lipid metabolism and transport were found in the CAL group, with significant differences compared with HCs. ELISA analysis indicated statistically significant differences in the urinary excretion of APOC3, APOA4, and FABPL in the CAL group compared with HCs. Twenty-four-hour urinary calcium excretion correlated significantly with concentrations of ApoC3 (r = 0.77, p < 0.001), and FABPL (r = 0.80, p = 0.005).


We provide proteomic data showing increased urinary excretion of lipid metabolism/transport-related proteins in children with kidney stones and hypercalciuria. These findings suggest that abnormalities in lipid metabolism might play a role in kidney stone formation.


Nephrolithiasis Urinary apolipoproteins Hypercalciuria Proteomics Children 


  1. 1.
    Torricelli FC, De SK, Gebreselassie S, Li I, Sarkissian C, Monga M (2014) Dyslipidemia and kidney stone risk. J Urol 191(3):667–672CrossRefPubMedGoogle Scholar
  2. 2.
    Kajikawa H (1998) The influence of dietary lipids on nephrolithiasis in rats. Nippon Hinyokika Gakkai Zasshi 89:931–938PubMedGoogle Scholar
  3. 3.
    Schmiedl A, Schwille PO, Bonucci E, Erben RG, Grayczyk A, Sharma V (2000) Nephrocalcinosis and hyperlipidemia in rats fed a cholesterol- and fat-rich diet: association with hyperoxaluria, altered kidney and bone minerals, and renal tissue phospholipid-calcium interaction. Urol Res 28(6):404–415CrossRefPubMedGoogle Scholar
  4. 4.
    Tsujihata M, Momohara C, Yoshioka I, Tsujimura A, Nonomura N, Okuyama A (2008) Atorvastatin inhibits renal crystal retention in a rat stone forming model. J Urol 180:2212–2217CrossRefPubMedGoogle Scholar
  5. 5.
    Iba A, Kohjimoto Y, Mori T, Kuramoto T, Nishizawa S, Fujii R, Nanpo Y, Matsumura N, Shintani Y, Inagaki T, Hara I (2010) Insulin resistance increases the risk of urinary stone formation in a rat model of metabolic syndrome. BJU Int 106:1550–1554CrossRefPubMedGoogle Scholar
  6. 6.
    Kadlec AO, Greco K, Fridirici ZC, Hart ST, Vellos T, Turk TM (2012) Metabolic syndrome and urinary stone composition: what factors matter most? Urology 80(4):805–810CrossRefPubMedGoogle Scholar
  7. 7.
    Inci M, Demirtas A, Sarli B, Akinsal E, Baydilli N (2012) Association between body mass index, lipid profiles, and types of urinary stones. Ren Fail 34(9):1140–1143CrossRefPubMedGoogle Scholar
  8. 8.
    Cameron MA, Sakhaee K, Moe OW (2005) Nephrolithiasis in children. Pediatr Nephrol 20:1587–1592CrossRefPubMedGoogle Scholar
  9. 9.
    Hoppe B, Kemper MJ (2010) Diagnostic examination of the child with nephrolithiasis or nephrocalcinosis. Pediatr Nephrol 25:403–413CrossRefPubMedGoogle Scholar
  10. 10.
    Thongboonkerd V (2007) Practical points in urinary proteomics. J Proteome Res 6(10):3881–3890CrossRefPubMedGoogle Scholar
  11. 11.
    Neilson KA, Ali NA, Muralidharan S, Mirzaei M, Mariani M, Assadourian G, Lee A, van Sluyter SC, Haynes PA (2011) Less label, more free: approaches in label-free quantitative mass spectrometry. Proteomics 11:535–553CrossRefPubMedGoogle Scholar
  12. 12.
    Brewer HB Jr, Shulman R, Herbert P, Ronan R, Wehrly K (1974) The complete amino acid sequence of alanine apolipoprotein (apoC-3), and apolipoprotein from human plasma very low density lipoproteins. J Biol Chem 249(15):4975–4984PubMedGoogle Scholar
  13. 13.
    Utermann G, Beisiegel U (1979) Apolipoprotein A-IV: a protein occurring in human mesenteric lymph chylomicrons and free in plasma. Isolation and quantification. Eur J Biochem 99(2):333–343CrossRefPubMedGoogle Scholar
  14. 14.
    Zheng C (2014) Updates on apolipoprotein CIII: fulfilling promise as a therapeutic target for hypertriglyceridemia and cardiovascular disease. Curr Opin Lipidol 25(1):35–39CrossRefPubMedGoogle Scholar
  15. 15.
    Zhang M, Zhu W, Li Y (2013) Small molecule inhibitors of human adipocyte Fatty Acid Binding Protein (FABP4). Med Chem 10(4):339–347CrossRefGoogle Scholar
  16. 16.
    Thumser AE, Moore JB, Plant NJ (2014) Fatty acid binding proteins: tissue-specific functions in health and disease. Curr Opin Clin Nutr Metab Care 17(2):124–129CrossRefPubMedGoogle Scholar
  17. 17.
    Eanes ED (1989) Biophysical aspects of lipid interaction with mineral: liposome model studies. Anat Rec 224(2):220–225CrossRefPubMedGoogle Scholar
  18. 18.
    Khan SR, Shevock PN, Hackett RL (1988) Presence of lipids in urinary stones: results of preliminary studies. Calcif Tissue Int 42(2):91–96CrossRefPubMedGoogle Scholar
  19. 19.
    Moorhead JF, Chan MK, El-Nahas M, Varghese Z (1982) Lipid nephrotoxicity in chronic progressive glomerular and tubulo-interstitial disease. Lancet 2(8311):1309–1311CrossRefPubMedGoogle Scholar
  20. 20.
    Khan SR, Glenton PA, Backov R, Talham DR (2002) Presence of lipids in urine, crystals and stones: implications for the formation of kidney stones. Kidney Int 62(6):2062–2072CrossRefPubMedGoogle Scholar

Copyright information

© IPNA 2017

Authors and Affiliations

  • Larisa Kovacevic
    • 1
  • Hong Lu
    • 1
  • Joseph A. Caruso
    • 2
  • Tuhina Govil-Dalela
    • 1
  • Ronald Thomas
    • 3
  • Yegappan Lakshmanan
    • 1
  1. 1.Department of Pediatric UrologyChildren’s Hospital of MichiganDetroitUSA
  2. 2.Institute of Environmental Health SciencesWayne State UniversityDetroitUSA
  3. 3.Department of StatisticsChildren’s Hospital of MichiganDetroitUSA

Personalised recommendations